Twin Tree Management, LP Sage Therapeutics, Inc. Call Options Transaction History

Twin Tree Management, LP

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2019 Nov 12, 2019	SELL	$140.29 - $189.96 $3.13 Million - $4.24 Million	-22,300 Closed	0 $0
Q2 2019 Aug 12, 2019	SELL	$157.85 - $183.09 $7.47 Million - $8.66 Million	-47,300 Reduced 67.96%	22,300 $4.08 Million
Q1 2019 May 10, 2019	BUY	$89.33 - $163.65 $2.55 Million - $4.68 Million	28,600 Added 69.76%	69,600 $11.1 Million
Q4 2018 Feb 13, 2019	BUY	$81.94 - $139.71 $81,940 - $139,710	1,000 Added 2.5%	41,000 $3.93 Million
Q3 2018 Nov 09, 2018	BUY	$138.11 - $169.04 $1.08 Million - $1.32 Million	7,800 Added 24.22%	40,000 $5.65 Million
Q2 2018 Aug 08, 2018	BUY	$140.36 - $175.76 $4.52 Million - $5.66 Million	32,200 New	32,200 $5.04 Million

194

49.5M

790K

440K

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $516M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

Get notified when there are updates to the investment portfolio of Twin Tree Management, LP, based on Form 13F filings with the SEC.

Stay updated on Twin Tree Management, LP with notifications on news.